Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 5127
Country/Region: Haiti
Year: 2007
Main Partner: International Child Care
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $910,000

Funding for Care: TB/HIV (HVTB): $910,000

Linked to Activities 9264, 9676, 9675.

SUMMARY: The project activities are carried out to promote and introduce the Tuberculosis (TB)/VIH integration activities in the network of the TB clinics. The emphasis areas are: Strategic Information management, training, human resources, infrastructure, development of network, linkages/referral systems, community mobilization/participation, policy and guidelines, quality assurance, quality improvement and supportive supervision. Primary target population includes TB patients, people leaving with HIV/AIDS, co-infected patients. The activities are developed through five departments of the country: 15 clinics in 13 communes of the North Regional Department, 15 clinics in six communes of the South Regional Department, 5 clinics in four communes of the South-East Regional Department, 10 clinics in 5 communes of Central Regional Department and 25 clinics in 10 communes of the West Regional Department. With FY 07 funding, 20 new clinics of the 5 other departments will join this network to place it at 90 units.

BACKGROUND: An estimated 20% of TB patients in Haiti are co-infected with HIV. Appropriate care can be easily provided to those target people already enrolled to health care in the TB clinics. International Child Care (ICC) started with the Centers for Disease Control and Prevention (CDC)'s technical and financial support in October 2005 a five years project aimed to ensure that more TB patients are receiving appropriate HIV screening and care, and at the same time that more HIV positive patients are being screened and treated for TB. The management of TB/HIV co-infected patient is introduced in 35 stand alone TB clinics and reinforced in 35 other sites with TB and voluntary counseling and testing (VCT) activities of which 19 are providing anti-retrovirals (ARVs). A TB-HIV integration committee joining together staff of the public sector and the main partners of the TB and the HIV/AIDS programs has been established at the central and departmental levels. A mixed mobile team strategy to monitor at regional level quality assurance and quality control has been also implemented. The accompagnateurs of the TB patients will also be oriented to assist the co-infected patients eligible to ARV.

ACTIVITY AND EXPECTED RESULTS: Activity 1: ICC will strengthen the capacity of selected TB clinics with high patient loads by training of services providers, maintaining a continuous supply of drugs, lab equipment and materials so better clinical services can be provided as well as psychosocial counseling of the co-infected TB patients. The ARV therapy will be provided through the network of USG-support ARV sites. Using the results of the needs assessment survey realized in 2006, the TB clinics will be equipped with basic material and supplies for the providing of the basic health care and support. The health personnel at the intermediate level have been already trained in the different aspects of the TB-HIV program integration.

Activity 2: A disease surveillance system for TB/HIV integrated services will be implemented at 35 TB Directly Observed Therapy (DOTS) clinics with the use of TB data collection tools and the installation of the TB database used by the National Program. The TB/HIV surveillance tools implemented by ICC in five regional departments will be introduced in 8 other TB clinics with the highest patient load in the 5 other regional departments. ICC will establish and maintain close coordination among the MOH Health Directorates in all 10 departments to ensure communication and collaboration.

Activity 3: Primary or secondary prevention of opportunistic infections in HIV/TB patients by isoniazid (INH) and Cotrimoxazole chimioprophylaxis, regular sensibilisation, promotion and provision of an hygiene kit containing condoms, water purifier, mosquito-net. This activity is intended to provide a better quality of life to the co-infected patients.

Activity 4: Operational research on HIV sero-surveillance among TB patients, and study of the prevalence of MDR in TB/HIV patients will be implemented in coordination with the GHESKIO interventions and support at the Sigueneau Hospital in Port-au-Prince (see the GHESKIO TB/HIV activity.) Through the regular supervision visits, the Quality Assurance and the Quality Control (QA/QC) of the collected data will be insured. Annual report on those studies will be published.

Activity 5: Reinforcement of the monitoring/evaluation process by realizing: quarterly meeting with the care providers, supervision mission by mixed mobile team strategy, regular follow-up visit for quality assurance and quality control.

Activity 6: Support to the central and regional departmental coordination committees of the National TB Program to assist in the review of norms and treatment algorithms. ICC will assist the MOH effort to establish national norms for the management of TB/HIV co-infection.

208 Coinfected patients will receive TB treatment and ARV treatment 11,600 TB patients tested for HIV